Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

Cluster analyses in NOVELTY patients with asthma and/or COPD yielded identifiable clusters, with several discriminatory features that differed from conventional diagnostic characteristics. The overlap between clusters suggests that they do not reflect discrete underlying mechanisms, and points to the need for identification of molecular endotypes and potential treatment targets across asthma and/or COPD.

Puedes leer el artículo completo aquí: https://www.sciencedirect.com/science/article/pii/S2213219823005494